Expression of CERS2 in invasive breast cancer tissues and its clinical significance.
10.3760/cma.j.issn.0529-5807.2013.04.012
- Author:
Yan-yan WANG
1
;
Li-yong GAO
;
Yue-hua ZHAO
;
Jin-yun LI
;
Qin LUO
;
Shao-hua FAN
Author Information
1. fshfly@126.com
- Publication Type:Journal Article
- MeSH:
Adenocarcinoma, Mucinous;
drug therapy;
metabolism;
pathology;
surgery;
Adult;
Aged;
Breast Neoplasms;
drug therapy;
metabolism;
pathology;
surgery;
Carcinoma, Ductal, Breast;
drug therapy;
metabolism;
pathology;
surgery;
Carcinoma, Lobular;
drug therapy;
metabolism;
pathology;
surgery;
Disease-Free Survival;
Female;
Follow-Up Studies;
Humans;
Lymphatic Metastasis;
MCF-7 Cells;
metabolism;
Mastectomy, Modified Radical;
Membrane Proteins;
metabolism;
Middle Aged;
Receptor, ErbB-2;
metabolism;
Sphingosine N-Acyltransferase;
metabolism;
Survival Rate;
Tumor Suppressor Proteins;
metabolism
- From:
Chinese Journal of Pathology
2013;42(4):267-268
- CountryChina
- Language:Chinese
